Treatment of Uncomplicated UTIs in Men
For uncomplicated UTIs in men, prescribe trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7 days as first-line therapy, unless local resistance exceeds 20%, in which case use a fluoroquinolone for 7 days. 1, 2
First-Line Antibiotic Selection
Trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg twice daily for 7 days is the preferred first-line treatment according to European Association of Urology guidelines 1, 2
Avoid TMP-SMX if local E. coli resistance exceeds 20% 1
Fluoroquinolones (ciprofloxacin or levofloxacin) serve as appropriate alternatives when local susceptibility patterns permit their use 1, 2
Nitrofurantoin may be considered for uncomplicated lower UTIs, though it is less commonly used due to concerns about inadequate prostate penetration 2
TMP-SMX is FDA-approved for UTIs caused by susceptible E. coli, Klebsiella, Enterobacter, Morganella morganii, Proteus mirabilis, and Proteus vulgaris 3
Treatment Duration Algorithm
When to Escalate to Parenteral Therapy
- Initiate IV antibiotics (ciprofloxacin, levofloxacin, ceftriaxone, cefepime, or piperacillin-tazobactam) if the patient appears systemically ill or has pyelonephritis 1
Critical Considerations Specific to Male UTIs
All UTIs in males are considered complicated by definition and require more thorough evaluation than female UTIs 2
UTIs in males are frequently associated with underlying urological abnormalities or complicating factors 2
Always obtain urine culture and susceptibility testing before initiating treatment to guide antibiotic selection 4
Consider urethritis and prostatitis as alternative or concurrent diagnoses in men presenting with UTI symptoms 4
Common Pitfalls to Avoid
Do not use treatment courses shorter than 7 days in men, as this is inadequate 2
Do not fail to consider prostatitis as a complicating factor that may require longer treatment (up to 14 days) 2
Do not overlook underlying structural or functional abnormalities that predispose to infection 2
Do not use TMP-SMX empirically in areas with high resistance rates (>20%) without culture guidance 1